News

This link will take you to the proposal to enter into an agreement with Smith & Nephew for medical devices in the following categories: Surgical Implants Medical and Surgical Instruments and Power Tools Smith & Nephew’s range of medical devices are proposed to be listed on the Pharmaceutical Schedule under a Pharmac agreement from 1 July 2026. A list of products included in the proposal is attached. Pharmac welcomes feedback on this proposal. To provide feedback, please submit it in...

Accurately diagnosing and treating impetigo and intertrigo in infants is important because their skin barrier is immature, infections spread faster, and complications can escalate before anyone realises what’s happening. In her talk at the Practical Update day, Specialist Dermatologist Lisa Connelly will focus on the diagnosis and management of impetigo and intertrigo (cradle cap) in children while also distinguishing these conditions from atopic eczema. She will also discuss scabies...

​

​

Conflict in the Middle East Suppliers are working closely with Pharmac to reduce any disruption to people in New Zealand. Where issues arise, we will communicate them on our website and through this email. Conflict in the Middle East: Impact on the supply chain New medicine supply notices Hydralazine hydrochloride (20 mg ampoule) there is a supply issue affecting the Apresoline brand (Pharmacode: 274550 and 2446227). We have listed two alternatives - they have important differences from...

Supply issue: We are writing to inform you of a supply issue: Viatris notified Pharmac that due to delays at the manufacturing facility, Montelukast tab 5mg is in short supply. Key Date: A new brand Montelukast tab 5mg (Relonchem) is available, and has been listed (funded) from 1 May 2026. Key messages: These tablets are for paediatric use, both brands are chewable, cherry flavour. Montelukast tab 5mg (Relonchem) is a pink coloured, circular, tablet. Montelukast tab 5mg (Viatris) is a white...